Evidence map›Paper›PMID 31589311›Full record

ArticleFEMS microbiology ecology2019

Priming of microcystin degradation in carbon-amended membrane biofilm communities is promoted by oxygen-limited conditions.

Marisa O D Silva, Jakob Pernthaler

Open access · bronzeAbstract read
In one paragraph

Article in FEMS microbiology ecology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marisa O D SilvaLimnological Station, Department of Plant and Microbial Biology, University of Zurich, Seestrasse 187, CH-8802 Kilchberg, Switzerland.
Jakob PernthalerLimnological Station, Department of Plant and Microbial Biology, University of Zurich, Seestrasse 187, CH-8802 Kilchberg, Switzerland.
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial biofilms are an important element of gravity-driven membrane (GDM) filtration systems for decentralized drinking water production. Mature biofilms fed with biomass from the toxic cyanobacterium Microcystis aeruginosa efficiently remove the cyanotoxin microcystin (MC). MC degradation can be 'primed' by prior addition of biomass from a non-toxic M. aeruginosa strain. Increased proportions of bacteria with an anaerobic metabolism in M. aeruginosa-fed biofilms suggest that this 'priming' could be due to higher productivity and the resulting changes in habitat conditions. We, therefore, investigated GDM systems amended with the biomass of toxic (WT) or non-toxic (MUT) M. aeruginosa strains, of diatoms (DT), or with starch solution (ST). After 25 days, these treatments were changed to receiving toxic cyanobacterial biomass. MC degradation established significantly more rapidly in MUT and ST than in DT. Oxygen measurements suggested that this was due to oxygen-limited conditions in MUT and ST already prevailing before addition of MC-containing biomass. Moreover, the microbial communities in the initial ST biofilms featured high proportions of facultative anaerobic taxa, whereas aerobes dominated in DT biofilms. Thus, the 'priming' of MC degradation in mature GDM biofilms seems to be related to the prior establishment of oxygen-limited conditions mediated by higher productivity.

Indexed as

BiofilmsBacterial ToxinsBiomassCarbonDiatomsMicrocystinsMicrocystisOxygenBacterial ToxinsCarbonmicrocystinMicrocystinsOxygenbacteriabiofilmshabitat primingmicrobial communitiesmicrocystin degradationoxygen-limited conditions

Identifiers

PMID31589311
PMCPMC6804753
OpenAlexW2980035259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.